Novel route for rapid biosynthesis of copper nanoparticles using aqueous extract of Calotropis procera L. latex and their cytotoxicity on tumor cells S Harne, A Sharma, M Dhaygude, S Joglekar, K Kodam, M Hudlikar Colloids and Surfaces B: Biointerfaces 95, 284-288, 2012 | 211 | 2012 |
Green synthesis of TiO2 nanoparticles by using aqueous extract of Jatropha curcas L. latex M Hudlikar, S Joglekar, M Dhaygude, K Kodam Materials Letters 75, 196-199, 2012 | 175 | 2012 |
Latex-mediated synthesis of ZnS nanoparticles: green synthesis approach M Hudlikar, S Joglekar, M Dhaygude, K Kodam Journal of Nanoparticle Research 14, 1-6, 2012 | 126 | 2012 |
Novel route for rapid biosynthesis of lead nanoparticles using aqueous extract of Jatropha curcas L. latex S Joglekar, K Kodam, M Dhaygude, M Hudlikar Materials letters 65 (19-20), 3170-3172, 2011 | 89 | 2011 |
Controlled multi‐functionalization facilitates targeted delivery of nanoparticles to cancer cells MS Hudlikar, X Li, IA Gagarinov, N Kolishetti, MA Wolfert, GJ Boons Chemistry–A European Journal 22 (4), 1415-1423, 2016 | 29 | 2016 |
Exploring Strain-Promoted 1,3-Dipolar Cycloadditions of End Functionalized Polymers GJB Petr A. Ledin, Nagesh Kolishetti, Manish Hudlikar Chemistry A European Journal 20, 8753-8760, 2014 | 10 | 2014 |
Exploration of bromodomain ligand-linker conjugation sites for efficient CBP/p300 heterobifunctional degrader activity CJO Manish Hudlikar, Praveen Kumar Tiwari, Sai Reddy Doda, Raghu Vannam ... Bioorganic & Medicinal Chemistry Letters 102, 129676-129681, 2024 | | 2024 |
WO2023056069_Degrader antibody conjugates and methods of using the same PJSCJ Manish Hudlikar, Ed Ha, Aaron Mallek, Gabriel Gonzalez US Patent WO2,023,056,069, 2023 | | 2023 |
WO2022204568_Maytansine antibody-conjugates and methods of using the same M Hudlikar, E Ha, P Jaminet, SC Jaminet, B Lutz US Patent PCT/US2022/022,041, 2022 | | 2022 |
WO2022026915_Anti-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same SCJ Manish Hudlikar, Edward Ha, Paul Jaminet US Patent App. 63/350,349, 2022 | | 2022 |
Novel ANTI-TM4SF1 antibody-drug conjugates and Methods of using the same M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA US Patent PCT/US2020/020,207, 2021 | | 2021 |
ANTI-TM4SF1 antibody-drug conjugates comprising cleavable linkers and methods of using the same MS JAMINET, Paul A. JAMINET, Shou-Ching S. HA, Edward HUDLIKAR, ... https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022026915&_cid …, 2021 | | 2021 |
WO2021222783_ANTI-TM4SF1 antibody drug conjugates and methods of using the same M HUDLIKAR, EH JAMINET, Paul A. JAMINET, Shou-Ching S. HA US Patent PCT/US2021/030,226, 2021 | | 2021 |
WO2021195598_Degrader antibody conjugates and methods of using the same MS HUDLIKAR, ... US Patent PCT/US2021/024,535, 2021 | | 2021 |
WO2020176794_Antibody drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same EH HUDLIKAR, Manish, JAMINET, Paul A. JAMINET, Shou-Ching S. HA US Patent PCT/US2020/020,207, 2020 | | 2020 |
Methods for the Preparation and Delivery of Highly Potent Paclitaxel Analogs through Site-Specific Antibody-Drug Glycoconjugates M Hudlikar, GJ Boons, X Li US Patent App. 62/561,027, 2017 | | 2017 |